Study Links Greater Number of Chronic Pain Sites to Risk for Dementia

WEDNESDAY, July 12, 2023 (HealthDay News) -- A greater number of chronic pain sites is associated with an increased risk for incident all-cause dementia and Alzheimer disease, according to a study recently published in BMC Medicine.
Jing Tian, from the University of Tasmania in Hobart, Australia, and colleagues examined whether a greater number of chronic pain sites is associated with a higher risk for dementia and its subtypes in a prospective cohort study involving 356,383 participants in the U.K. Biobank. Participants were categorized as having no chronic pain; chronic pain in one, two, three, and four sites; and pain "all over the body."
The researchers found that 4,959 participants developed dementia during a median follow-up of 13 years. A greater number of chronic pain sites was associated with an increased risk for incident all-cause dementia and Alzheimer disease in a dose-response manner (hazard ratios, 1.08 and 1.09 per one-site increase, respectively), but not vascular and frontotemporal dementia, after adjustment for sociodemographic factors, lifestyle, comorbidities, pain medications, psychological problems, and sleep factors. In a subsample of patients who underwent a fluid intelligence test, there was no significant association observed between the number of chronic pain sites and the risk for incident all-cause dementia.
"These findings suggest that chronic pain in multiple sites may represent an accessible marker to assess an individual's dementia risk and identify 'at-risk' individuals at early stages," the authors write.
Related Posts
El ejercicio puede ayudar a luchar contra el cáncer de colon, aunque el paciente sea obeso
JUEVES, 17 de noviembre de 2022 (HealthDay News) -- Hacer una actividad física...
DOACs Cut Recurrent VTE in Adults With Cancer-Related Thrombosis
THURSDAY, Feb. 17, 2022 (HealthDay News) -- For adults with cancer-associated...
FDA Questions Strength of Johnson & Johnson’s Booster Shot Data
WEDNESDAY, Oct. 13, 2021 (HealthDay News) -- In a development that could mean...
FDA Approves First Drug Meant to Ease Alzheimer’s-Linked Agitation
THURSDAY, May 11, 2023 (HealthDay News) -- A medication to treat agitation in...